Acute Decompensated Heart Failure clinical trials

Explore recruiting acute decompensated heart failure clinical trials.

Recruiting acute decompensated heart failure studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Acute Decompensated Heart Failure trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

EMpagliflozin and daPAgliflozin in patients hospiTalized for acute decompensated Heart failure (EMPATHY) – a phase III Trial

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Randomized double-blind trial to study the benefit of Colchicine in Patients with Acutely Decompensated Heart Failure

Spain, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Effects of continued administration of empagliflozin in patients with heart failure on active SGLT2 inhibitor treatment admitted for acute decompensated heart failure

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

OPTIMAL DIURETIC THERAPIES FOR ACUTE HEART FAILURE WITH VOLUME OVERLOAD

Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

RandomizEd trial to DEtermine the efficacy and safety of FINErenone on morbidity and mortality among heart failure patients with left ventricular ejection fraction greater than or equal to 40% hospitalized due to an episode of acute decompensated Heart Failure (REDEFINE-HF)

Poland, Czechia, Hungary, Greece, Lithuania, Germany +9 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Multicenter, Randomized, Placebo-Controlled, Parallel Group Trial on the Safety and Efficacy of Istaroxime for Cardiogenic Shock SCAI Stage C (SEISMiC-C)

Poland, Czechia, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Acute Decompensated Heart Failure trials by city

Acute Decompensated Heart Failure in Toronto Acute Decompensated Heart Failure in Vancouver Acute Decompensated Heart Failure in Montreal Acute Decompensated Heart Failure in Calgary Acute Decompensated Heart Failure in Edmonton Acute Decompensated Heart Failure in Ottawa Acute Decompensated Heart Failure in Winnipeg Acute Decompensated Heart Failure in Quebec City Acute Decompensated Heart Failure in Hamilton Acute Decompensated Heart Failure in Kitchener Acute Decompensated Heart Failure in London Acute Decompensated Heart Failure in Halifax Acute Decompensated Heart Failure in New York Acute Decompensated Heart Failure in Los Angeles Acute Decompensated Heart Failure in Chicago Acute Decompensated Heart Failure in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease